位置:首页 > 蛋白库 > VP3_ROTSH
VP3_ROTSH
ID   VP3_ROTSH               Reviewed;         835 AA.
AC   A2T3S5;
DT   24-MAR-2009, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 1.
DT   23-FEB-2022, entry version 56.
DE   RecName: Full=Protein VP3 {ECO:0000255|HAMAP-Rule:MF_04128};
DE   Includes:
DE     RecName: Full=2',5'-phosphodiesterase {ECO:0000255|HAMAP-Rule:MF_04128};
DE              EC=3.1.4.- {ECO:0000255|HAMAP-Rule:MF_04128, ECO:0000269|PubMed:23878220};
DE   Includes:
DE     RecName: Full=mRNA guanylyltransferase {ECO:0000255|HAMAP-Rule:MF_04128};
DE              EC=2.7.7.50 {ECO:0000255|HAMAP-Rule:MF_04128, ECO:0000269|PubMed:10603323};
DE   Includes:
DE     RecName: Full=mRNA (guanine-N(7))-methyltransferase {ECO:0000255|HAMAP-Rule:MF_04128};
DE              EC=2.1.1.56 {ECO:0000255|HAMAP-Rule:MF_04128, ECO:0000269|PubMed:10603323};
OS   Rotavirus A (isolate RVA/Monkey/South Africa/SA11-H96/1958/G3P5B[2]) (RV-A)
OS   (Simian Agent 11 (isolate SI/South Africa/H96/58)).
OC   Viruses; Riboviria; Orthornavirae; Duplornaviricota; Resentoviricetes;
OC   Reovirales; Reoviridae; Sedoreovirinae; Rotavirus; Rotavirus A.
OX   NCBI_TaxID=450149;
OH   NCBI_TaxID=60710; Chlorocebus pygerythrus (Vervet monkey) (Cercopithecus pygerythrus).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=17059839; DOI=10.1016/j.virol.2006.09.024;
RA   Small C., Barro M., Brown T.L., Patton J.T.;
RT   "Genome heterogeneity of SA11 rotavirus due to reassortment with 'O'
RT   agent.";
RL   Virology 359:415-424(2007).
RN   [2]
RP   INTERACTION WITH VP2.
RX   PubMed=9420216; DOI=10.1128/jvi.72.1.201-208.1998;
RA   Zeng C.Q.-Y., Estes M.K., Charpilienne A., Cohen J.;
RT   "The N terminus of rotavirus VP2 is necessary for encapsidation of VP1 and
RT   VP3.";
RL   J. Virol. 72:201-208(1998).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10603323; DOI=10.1006/viro.1999.0029;
RA   Chen D., Luongo C.L., Nibert M.L., Patton J.T.;
RT   "Rotavirus open cores catalyze 5'-capping and methylation of exogenous RNA:
RT   evidence that VP3 is a methyltransferase.";
RL   Virology 265:120-130(1999).
RN   [4]
RP   FUNCTION, DOMAIN, CATALYTIC ACTIVITY, MUTAGENESIS OF HIS-718 AND HIS-797,
RP   AND ACTIVE SITE.
RX   PubMed=23878220; DOI=10.1073/pnas.1306917110;
RA   Zhang R., Jha B.K., Ogden K.M., Dong B., Zhao L., Elliott R., Patton J.T.,
RA   Silverman R.H., Weiss S.R.;
RT   "Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize
RT   antiviral innate immunity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:13114-13119(2013).
RN   [5]
RP   DOMAIN.
RX   PubMed=24899176; DOI=10.1128/jvi.00923-14;
RA   Ogden K.M., Snyder M.J., Dennis A.F., Patton J.T.;
RT   "Predicted structure and domain organization of rotavirus capping enzyme
RT   and innate immune antagonist VP3.";
RL   J. Virol. 88:9072-9085(2014).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.39 ANGSTROMS) OF 696-835, AND DOMAIN.
RX   PubMed=25758703; DOI=10.1002/prot.24794;
RA   Brandmann T., Jinek M.;
RT   "Crystal structure of the C-terminal 2',5'-phosphodiesterase domain of
RT   group A rotavirus protein VP3.";
RL   Proteins 83:997-1002(2015).
CC   -!- FUNCTION: Multifunctional enzyme involved in mRNA capping. Catalyzes
CC       the formation of the 5' cap structure on the viral plus-strand
CC       transcripts. Specifically binds to GTP and displays guanylyltransferase
CC       and methyltransferase activities. Has affinity for ssRNA but not for
CC       dsRNA. Capping activity is non-specific and caps RNAs that initiate
CC       with either a G or an A residue. Together with VP1 polymerase, forms a
CC       VP1-VP3 complex positioned near the channels situated at each of the
CC       five-fold vertices of the core. Following infection, the outermost
CC       layer of the virus is lost, leaving a double-layered particle (DLP)
CC       made up of the core and VP6 shell. VP1 then catalyzes the transcription
CC       of fully conservative plus-strand genomic RNAs that are capped by VP3
CC       and extruded through the DLP's channels into the cytoplasm where they
CC       function as mRNAs for translation of viral proteins. DLPs probably have
CC       an RNA triphosphatase activity as well, whereas open cores do not.
CC       {ECO:0000255|HAMAP-Rule:MF_04128, ECO:0000305|PubMed:10603323}.
CC   -!- FUNCTION: Counteracts the host innate immune response thanks to its
CC       phosphodiesterase that degrades the 5'-triphosphorylated, 2'-5' linked
CC       adenylate oligomers produced by the host cell IFN-inducible 2',5'-
CC       oligoadenylate synthetase (OAS). The host RNaseL is therefore not
CC       activated. {ECO:0000255|HAMAP-Rule:MF_04128,
CC       ECO:0000269|PubMed:23878220}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'-
CC         end (5'-triphosphoguanosine)-(ribonucleoside) in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_04128,
CC         ECO:0000269|PubMed:10603323};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-(ribonucleoside) in mRNA +
CC         S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:67008, Rhea:RHEA-COMP:17166, Rhea:RHEA-
CC         COMP:17167, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167617; EC=2.1.1.56; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_04128, ECO:0000269|PubMed:10603323};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-triphosphoadenylyl-(2'->5')-adenylyl-(2'->5')-adenosine + 2
CC         H2O = 2 AMP + ATP + 2 H(+); Xref=Rhea:RHEA:45964, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:67143,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000255|HAMAP-Rule:MF_04128,
CC         ECO:0000269|PubMed:23878220};
CC   -!- SUBUNIT: Interacts with VP1 (By similarity). Interacts with VP2
CC       (PubMed:9420216). {ECO:0000255|HAMAP-Rule:MF_04128,
CC       ECO:0000269|PubMed:9420216}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000255|HAMAP-Rule:MF_04128}.
CC       Note=Attached inside the inner capsid as a minor component. There are
CC       about 11 to 12 copies per virion. {ECO:0000255|HAMAP-Rule:MF_04128}.
CC   -!- DOMAIN: Contains a bipartite N7-methyltransferase domain, a 2'-O-
CC       methyltransferase domain and a GTase/RTPase domain. The C-terminus
CC       contains a phosphodiesterase domain that degrades the 5'-
CC       triphosphorylated, 2'-5' linked adenylate oligomers produced by the
CC       host cell in response to IFN stimulation. {ECO:0000255|HAMAP-
CC       Rule:MF_04128, ECO:0000269|PubMed:23878220,
CC       ECO:0000269|PubMed:24899176, ECO:0000269|PubMed:25758703}.
CC   -!- SIMILARITY: Belongs to the rotavirus VP3 family. {ECO:0000255|HAMAP-
CC       Rule:MF_04128}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ838645; ABG75824.1; -; Genomic_RNA.
DR   RefSeq; YP_002302228.1; NC_011508.2.
DR   PDB; 5AF2; X-ray; 1.39 A; A/B/C/D=696-835.
DR   PDBsum; 5AF2; -.
DR   SMR; A2T3S5; -.
DR   GeneID; 7011370; -.
DR   KEGG; vg:7011370; -.
DR   Proteomes; UP000001119; Genome.
DR   GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-UniRule.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004482; F:mRNA (guanine-N7-)-methyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0004484; F:mRNA guanylyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0008081; F:phosphoric diester hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0106005; P:RNA 5'-cap (guanine-N7)-methylation; IDA:UniProtKB.
DR   GO; GO:0039503; P:suppression by virus of host innate immune response; IEA:UniProtKB-KW.
DR   CDD; cd20757; capping_2-OMTase_Rotavirus; 1.
DR   HAMAP; MF_04124; Rota_VP3; 1.
DR   HAMAP; MF_04128; Rota_VP3_A; 1.
DR   InterPro; IPR039573; NS2A-like.
DR   InterPro; IPR011181; VP3_Rotav.
DR   Pfam; PF05213; Corona_NS2A; 1.
DR   Pfam; PF06929; Rotavirus_VP3; 1.
DR   PIRSF; PIRSF004015; LigT_rotavirus; 1.
DR   PROSITE; PS51589; SAM_MT56_VP3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; GTP-binding; Host-virus interaction; Hydrolase;
KW   Inhibition of host innate immune response by virus; Methyltransferase;
KW   mRNA capping; mRNA processing; Multifunctional enzyme; Nucleotide-binding;
KW   Nucleotidyltransferase; Reference proteome; RNA-binding;
KW   S-adenosyl-L-methionine; Transferase; Viral immunoevasion; Virion.
FT   CHAIN           1..835
FT                   /note="Protein VP3"
FT                   /id="PRO_0000367814"
FT   REGION          171..245
FT                   /note="N7-methyltransferase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000269|PubMed:24899176"
FT   REGION          246..428
FT                   /note="2'-O-methyltransferase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000269|PubMed:24899176"
FT   REGION          429..555
FT                   /note="N7-methyltransferase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000269|PubMed:24899176"
FT   REGION          556..693
FT                   /note="GTase/RTPase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000269|PubMed:24899176"
FT   REGION          693..835
FT                   /note="2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000269|PubMed:23878220"
FT   ACT_SITE        718
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000269|PubMed:23878220, ECO:0000305|PubMed:25758703"
FT   ACT_SITE        720
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000305|PubMed:25758703"
FT   ACT_SITE        797
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000269|PubMed:23878220, ECO:0000305|PubMed:25758703"
FT   ACT_SITE        799
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128,
FT                   ECO:0000305|PubMed:25758703"
FT   MUTAGEN         718
FT                   /note="H->A: Complete loss of 2'-5'-phosphodiesterase
FT                   activity; when associated with A-797."
FT                   /evidence="ECO:0000269|PubMed:23878220"
FT   MUTAGEN         797
FT                   /note="H->A: Complete loss of 2'-5'-phosphodiesterase
FT                   activity; when associated with A-718."
FT                   /evidence="ECO:0000269|PubMed:23878220"
FT   STRAND          699..706
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          714..716
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          718..725
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   HELIX           728..730
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   HELIX           731..740
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   HELIX           742..746
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          751..759
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          762..766
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   HELIX           771..783
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          787..792
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          797..803
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          809..814
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          817..824
FT                   /evidence="ECO:0007829|PDB:5AF2"
FT   STRAND          829..833
FT                   /evidence="ECO:0007829|PDB:5AF2"
SQ   SEQUENCE   835 AA;  98069 MW;  B761FCA189B7FBB5 CRC64;
     MKVLALRHSV AQVYADTQVY VHDDTKDSYE NAFLISNLTT HNILYLNYSI KTLEILNKSG
     IAAIALQSLE ELFTLIRCNF TYDYELDIIY LHDYSYYTNN EIRTDQHWIT KTNIEEYLLP
     GWKLTYVGYN GSETRGHYNF SFKCQNAATD DDLIIEYIYS EALDFQNFML KKIKERMTTS
     LPIARLSNRV FRDKLFPSLL KEHKNVVNVG PRNESMFTFL NYPTIKQFSN GAYLVKDTIK
     LKQERWLGKR ISQFDIGQYK NMLNVLTAIY YYYNLYKSKP IIYMIGSAPS YWIYDVRHYS
     DFFFETWDPL DTPYSSIHHK ELFFINDVKK LKDNSILYID IRTDRGNADW KKWRKTVEEQ
     TINNLDIAYE YLRTGKAKVC CVKMTAMDLE LPISAKLLHH PTTEIRSEFY LLLDTWDLTN
     IRRFIPKGVL YSFINNIITE NVFIQQPFKV KVLNDSYIVA LYALSNDFNN RSEVIKLINN
     QKQSLITVRI NNTFKDEPKV GFKNIYDWTF LPTDFDTKEA IITSYDGCLG LFGLSISLAS
     KPTGNNHLFI LSGTDKYYKL DQFANHTSIS RRSHQIRFSE SATSYSGYIF RDLSNNNFNL
     IGTNIENSVS GHVYNALIYY RYNYSFDLKR WIYLHSIDKV DIEGGKYYEL APIELIYACR
     SAKEFATLQD DLTVLRYSNE IENYINTVYS ITYADDPNYF IGIQFRNIPY KYDVKIPHLT
     FGVLHISDNM VPDVIDILKI MKNELFKMDI TTSYTYMLSD GIYVANVSGV LSTYFKIYNV
     FYKNQITFGQ SRMFIPHITL SFNNMRTVRI ETTKLQIKSI YLRKIKGDTV FDMVE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024